Orion Biotech Opportunities Corp.
Market price today
Orion Biotech Opportunities Corp. (ORIAU) Stock Split, History Data
Working capital analysis
In terms of working capital, Orion Biotech Opportunities Corp. maintains a healthy position. The total current assets of the company are valued at $439320. This represents a growth rate of -67.531% compared to the previous year. Breaking down the current assets, the cash and investments are worth $265717, exhibiting a growth rate of -62.705% year-on-year. The receivables, another significant portion of the current assets, are valued at $0. The year-on-year growth rate for receivables is NaN%. The inventory, which forms a critical part of the assets, is valued at $0. This represents a healthy year-on-year growth of NaN% On the liabilities side, the company's current liabilities total $67593. This reflects a growth rate of -17.197% over the previous year, indicating the company's financial obligations are well under control.
|Cash and investments||0.27||0.71|
|Total Current Assets||0.44||1.35|
|Short Term Debt||0.00||0.00|
|Other Current Liab||0.06||0.07|
When examining the capital structure of Orion Biotech Opportunities Corp., it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $203332786. When juxtaposed with the previous year, this marks a growth rate of 14833.251%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $8331760. Compared to the prior year, this reflects a growth rate of -44.884%. The long-term debt forms a sizable part of these liabilities, coming in at $0. Over the last year, the long-term debt has grown by NaN%. On the asset side, the cash and equivalent reserves are worth $265717. The year-on-year growth of these reserves is -62.705%. The company's common stock, another important asset, holds a value of $202793965, growing at a rate of 1.397% from the previous year. Finally, the company's retained earnings stand at $-7792939, marking a growth rate of -43.348% year-over-year. These earnings represent the profits that Orion Biotech Opportunities Corp. has chosen to reinvest in the business rather than distribute as dividends.
Long term debt
Cash and eqv
Historical dividend key summary
Orion Biotech Opportunities Corp.'s dividend per share is $0, showing the earnings shared with shareholders per share. It has grown by 0.000% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.
Net earnings per share (EPS)
Orion Biotech Opportunities Corp. has an EPS of $0.14, which signifies the profit allocated per share of common stock. With a growth rate of % this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.
Orion Biotech Opportunities Corp. (ORIAU) stock split history
Understanding the historical stock splits of Orion Biotech Opportunities Corp. (ORIAU) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on N/A with a ratio of N/A:N/A. Throughout its history, the company has undergone 0 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.
Frequently Asked Question
What is the latest historical split date of the company?
The latest historical split date is N/A.
What is firm free cah flow per share (FCF per share)?
The free cah flow per share (FCF per share) is -0.019.
What is company revenue per share?
The company revenue per share is 0.000.
What are firm earnings per share?
The firm earnings per share is 560108.862.
What is Orion Biotech Opportunities Corp. (ORIAU) ROIC (return on capital)?
Orion Biotech Opportunities Corp. (ORIAU) ROIC (return on capital) is -0.004.
What is dividend per share figure?
The dividend per share is 0.000
What is enterprise plowback ratio?
Orion Biotech Opportunities Corp. (ORIAU) plowback ratio is N/A
What is firm enterprise value (EV)?
The enterprise value (EV) is -24.254
What is company debt to equity ratio?
The debt to equity ratio is 0.000
What are debt ratio numbers?
The debt ratio is 0.000
What is company price to sales ratio?
The price to sales ratio is 0.000